Product Information
ARIPIPRAZOLE 1 MG/ML SOLUTION is a generic product labeled by Aurobindo Pharma Limited, priced at $0.5002 per ML under NDC 59651011055. Its NADAC has been published 334 times since Apr 3, 2019.
FDA first approved this application on Jan 29, 2019. Its Orange Book therapeutic-equivalence code is AA.
Strength
1 mg/mL
Manufacturer
Aurobindo Pharma LimitedNDC
59651011055
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
8/20/2025
Active Ingredients
ARIPIPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA210479FDA Approved
1/29/2019
TE Code
AA
On Market Since
1/29/2019
Pharmacological Classes
Price Statistics
The NADAC for ARIPIPRAZOLE 1 MG/ML SOLUTION has been published 334 times since Apr 3, 2019, and over the history we have for it it has declined 78.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5002 per ML |
|---|---|
| All-time high | $3.0040 (May 15, 2019) |
| All-time low | $0.4079 (Jul 17, 2024) |
| Median price | $1.0842 |
| Average price | $1.2706 |
| Largest weekly change | +55.1% (Mar 22, 2023) |
| Weeks tracked | 334 |
| Tracking since | Apr 3, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-49.7%
5Y
-58.8%
All
-78.0%
Last surveyed Aug 20, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 34% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Aripiprazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Atypical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ARIPIPRAZOLE 1 MG/ML SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for ARIPIPRAZOLE 1 MG/ML SOLUTION, manufactured by Aurobindo Pharma Limited, is $0.5002 per ML (NDC 59651011055), effective Aug 20, 2025.
How has the price of ARIPIPRAZOLE 1 MG/ML SOLUTION changed over time?
Over the history we have for it, the NADAC for ARIPIPRAZOLE 1 MG/ML SOLUTION has declined 78.0%. It has been tracked across 334 weekly CMS publications since Apr 3, 2019.
What are the highest and lowest recorded NADAC prices for ARIPIPRAZOLE 1 MG/ML SOLUTION?
Since Apr 3, 2019, the NADAC for ARIPIPRAZOLE 1 MG/ML SOLUTION has ranged from a low of $0.4079 (Jul 17, 2024) to a high of $3.0040 (May 15, 2019), with a median of $1.0842 per ML.
Are there cheaper alternatives to ARIPIPRAZOLE 1 MG/ML SOLUTION?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ARIPIPRAZOLE 1 MG/ML SOLUTION, is $0.3312 per ML — about 34% below ARIPIPRAZOLE 1 MG/ML SOLUTION.
Who manufactures ARIPIPRAZOLE 1 MG/ML SOLUTION?
ARIPIPRAZOLE 1 MG/ML SOLUTION (NDC 59651011055) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.